Note 4 - Debt
|6 Months Ended|
Jun. 30, 2017
|Notes to Financial Statements|
|Debt Disclosure [Text Block]||
October 2014,we entered into an agreement to refinance and amend the terms of our
March 2013loan and security agreement. In conjunction with the loan amendment, we issued the lender a
five-year common stock purchase warrant to purchase
5,784shares of common stock at an exercise price of
$34.58per share. The warrant contains standard anti-dilution protection but does
notcontain any anti-dilution price protection for subsequent offerings and is classified in equity.
We also incurred expenses with various
thirdparties in connection with the loan amendment, consisting of approximately
2,163shares of common stock valued at approximately
three-year common stock purchase warrant to purchase
4,475shares at an exercise price of
$34.58per share. The warrant has terms substantially similar to the lender warrant and is classified as equity.
The amended loan was paid off in its entirety in
April 2017,pursuant to its terms.
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
Reference 1: http://www.xbrl.org/2003/role/presentationRef